Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
docetaxel (taxotere) (2 trials)
Filgrastim (neupogen) (2 trials)
nanocovax (2 trials)
trastuzumab (herceptin) (2 trials)
peginterferon lambda-1a (1 trial)
Breast Neoplasms (Phase 3)
Hepatitis (Phase 1)
Hepatitis A (Phase 1)
Hepatitis C (Phase 1)
Hepatitis C, Chronic (Phase 1)
Trials (7 total)
Trial APIs (5 total)